Xiaowen Tang

5.3k total citations · 2 hit papers
238 papers, 3.1k citations indexed

About

Xiaowen Tang is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Xiaowen Tang has authored 238 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Hematology, 64 papers in Oncology and 63 papers in Molecular Biology. Recurrent topics in Xiaowen Tang's work include Acute Myeloid Leukemia Research (74 papers), Hematopoietic Stem Cell Transplantation (68 papers) and Acute Lymphoblastic Leukemia research (41 papers). Xiaowen Tang is often cited by papers focused on Acute Myeloid Leukemia Research (74 papers), Hematopoietic Stem Cell Transplantation (68 papers) and Acute Lymphoblastic Leukemia research (41 papers). Xiaowen Tang collaborates with scholars based in China, United States and Canada. Xiaowen Tang's co-authors include Depei Wu, Depei Wu, Haiping Dai, Li Yang, Zhengtao Wang, Qiaoling Yang, Xiaming Zhu, Huiying Qiu, Yue Han and Lin Yang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Xiaowen Tang

219 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.

2018 356 citations Xiaowen Tang, Lin Yang et al. PubMed profile →
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

2021 150 citations Xiaowen Tang, Depei Wu et al. profile →

Peers

Countries citing papers authored by Xiaowen Tang

Since Specialization

Citations

This map shows the geographic impact of Xiaowen Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowen Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowen Tang more than expected).

Fields of papers citing papers by Xiaowen Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowen Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowen Tang. The network helps show where Xiaowen Tang may publish in the future.

Co-authorship network of co-authors of Xiaowen Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowen Tang. A scholar is included among the top collaborators of Xiaowen Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowen Tang. Xiaowen Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Outcomes of CD7 CAR‐T Cell Therapy in Relapsed or Refractory T‐Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients 2025 ·Hematological Oncology ·(unknown), Yujie Liu, (unknown), Jiaqi Li, Ying Wang, Suning Chen, Xiaowen Tang, Lin Yang, (unknown), Yang Xu, (unknown)	2
2	Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia 2025 ·Clinical Lymphoma Myeloma & Leukemia ·Zhibo Zhang, Jia Yin, Jun Wang, Xuefeng He, Xiaohui Hu, Haiwen Huang, Limin Liu, Miao Miao, Ying Wang, Huiying Qiu, Xiaowen Tang, Depei Wu, Xiao Ma, Weiyang Li	0
3	CRM197-scaffolded vaccines designed by epitope grafting ameliorate cognitive decline in an Alzheimer's disease model 2024 ·International Journal of Biological Macromolecules ·Wei Cui, Ying Wang, Xiaowen Tang, (unknown), (unknown), Tiantian Gu, Jianning Mao, Wenjie Li, (unknown), Zhun Wei	2
4	Comparative study of job burnout in Shanghai‐based nurses against Maslach norm and Hangzhou norm 2024 ·International Nursing Review ·Xiaojuan Yu, (unknown), (unknown), Xiaowen Tang, (unknown)	1
5	Comparing the Efficacy and Safety of VAC (Venetoclax, Azacitidine, Chidamide) and VA Regimens As Induction Therapy for Newly Diagnosed Patients with Immunophenotypically Mature Monocytic AML 2024 ·Blood ·(unknown), (unknown), Miao Wang, (unknown), Hao Zhang, Chunyan Chen, (unknown), Haiping Dai, Ying Wang, Miao Miao, Yue Han, Xiaowen Tang, Huiying Qiu, Suning Chen, (unknown), Depei Wu, Zheng Li, Shengli Xue	1
6	Network pharmacology-based investigation and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia 2024 ·European journal of medical research ·(unknown), Mingming Xu, (unknown), Yangzi Li, Depei Wu, Xiaowen Tang	2
7	Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients 2024 ·Leukemia Research ·(unknown), Qingya Cui, Sining Liu, (unknown), Wei Cui, Mengyun Li, (unknown), (unknown), Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang	0
8	Rituximab Improves Clinical Outcomes of CAR-T Therapy for r/r B-ALL Via Sensitizing Leukemia Cells to CAR-T-Mediated Cytotoxicity and Reducing CAR-T Exhaustion 2023 ·Blood ·Yangzi Li, Sining Liu, Qingya Cui, Lingling Liu, (unknown), Wei Cui, Mengyun Li, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang	5
9	Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning 2023 ·Frontiers in Immunology ·Hong Wang, Qingyuan Wang, Jiaqian Qi, Xue-Qian Li, (unknown), Huiying Qiu, Chengcheng Fu, Xiaowen Tang, Changgeng Ruan, Depei Wu, Yuexin Han	2
10	[Clinical efficacy and safety of venetoclax combined with multidrug chemotherapy in the treatment of 15 patients with relapsed or refractory early T-cell precursor acute lymphoblastic leukemia]. 2023 ·PubMed ·(unknown), (unknown), Yue Pu, Yi Liu, Xiangpeng Kong, (unknown), Jian Zhang, Baoquan Song, Shengli Xue, Xiaowen Tang, Huiying Qiu, Depei Wu	2
11	Patterns of distant metastases in patients with triple‐negative breast cancer—A population‐based study 2023 ·SHILAP Revista de lepidopterología ·Yang Gao, (unknown), (unknown), (unknown), (unknown), Xiaowen Tang, (unknown)	5
12	Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T‐cell precursor acute lymphoblastic leukemia 2021 ·Hematological Oncology ·(unknown), Jiaqian Qi, Yuanxin Zhu, Yang Xu, Feng Chen, Shengli Xue, Miao Miao, Suning Chen, Yue Han, Xiaowen Tang, Huiying Qiu, Aining Sun, Depei Wu, Ying Wang	2
13	Safety and efficacy of different doses of anthracyclines combined with arsenic trioxide and all-trans retinoic acid in the treatment of de novo acute promyelocytic leukemia 2021 ·Hematology ·(unknown), Ke Peng, Haixia Zhou, Depei Wu, Suning Chen, Huiying Qiu, Yue Han, Caixia Li, Xiao Ma, (unknown), Xiaowen Tang, Xiaohui Hu	2
14	Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation 2020 ·Bone Marrow Transplantation ·(unknown), Jian Zhang, Xinyou Zhang, (unknown), Lili Zhou, Xiebing Bao, Yue Han, Miao Miao, Caixia Li, Chengcheng Fu, Suning Chen, Xiaowen Tang, Depei Wu, Huiying Qiu	21
15	Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases 2020 ·Bone Marrow Transplantation ·Limin Liu, Yanming Zhang, (unknown), Huifen Zhou, Qingyuan Wang, Huiying Qiu, Xiaowen Tang, Yue Han, Chengcheng Fu, Zhengming Jin, Suning Chen, Aining Sun, Miao Miao, Depei Wu	12
16	shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia 2019 ·Blood ·Liqing Kang, Xiaowen Tang, Nan Xu, Minghao Li, Jingwen Tan, Wei Qi, Zhou Yu, Xiaoyan Lou, Shengli Xue, Xin Li, Jian Zhang, Jia Chen, Zhenkun Wang, Caixia Li, (unknown), Depei Wu, Lei Yu	2
17	Impact of cyclosporine‐A concentration in T‐cell replete haploidentical allogeneic stem cell transplantation 2018 ·Clinical Transplantation ·Xiaofei Yang, Shuo Yang, Aining Sun, Huiying Qiu, Xiaowen Tang, Yue Han, Depei Wu	5
18	MVP Combined with FC As Lymphocyte-Depleting Chemotherapy before CAR-T Treatment Can Reduce the Incidence of Severe Cytokine Release Syndrome for Relapsed/Refractory ALL Patients with High Tumour Burden 2017 ·Blood ·Xiaowen Tang, Zheng Li, Ting Xu, Haiping Dai, Jia Yin, (unknown), Shengli Xue, Yang Xu, Xiaming Zhu, Liqing Kang, Yujie Xia, Lei Yu, Depei Wu	0
19	Outcomes of CAG Regimen for Refractory Biphenotypic Acute Leukemia Patients 2009 ·Chinese Medical Sciences Journal ·Guangsheng He, Xiang Zhang, Depei Wu, (unknown), Zhengming Jin, Huiying Qiu, Miao Miao, Xiaowen Tang, Zhengzheng Fu, Yue Han	4
20	Mitochondrial ND5 T12338C, tRNA^Cys T5802C, and tRNA^Thr G15927A variants may have a modifying role in the phenotypic manifestation of deafness‐associated 12S rRNA A1555G mutation in three Han Chinese pedigrees 2008 ·American Journal of Medical Genetics Part A ·Bobei Chen, Dongmei Sun, Li Yang, (unknown), Aifen Yang, Yi Zhu, Jianyue Zhao, Yingying Chen, (unknown), (unknown), Xinjian Wang, Ronghua Li, Xiaowen Tang, Jindan Wang, Zhihua Tao, Jianxin Lü, (unknown), (unknown)	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact